Antifungal activity of Gracilaria corticata methanol extract against Trichophyton mentagrophytes, Microsporum canis, and Microsporum gypseum on rat dermatophytosis models

Document Type : Original Articles


1 Division of Physiology, Department of Basic Sciences, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran

2 Department of Veterinary Surgery, Science and Research Branch, Islamic Azad University, Tehran, Iran

3 Department of Mycology, Faculty of Medical sciences, Tonekabon Branch, Islamic Azad University, Tonekabon, Iran

4 Department of Pathobiology, School of Veterinary science and Research Branch, Islamic Azad University, Tehran, Iran


Background and Purpose: Dermatophytosis is one of the most prevalent zoonotic diseases. Increased resistance of dermatophytosis causing pathogens against antidermatophytic agents highlights the need for alternative medicine with higher efficiency and lower side effects. In the present study, the in vitro antifungal activities of different concentrations of Gracilaria corticata methanol extract against Trichophyton mentagrophytes, Microsporum canis, and Microsporum gypseum were assessed and their efficacy was evaluated in rat dermatophytosis models.
Materials and Methods: The broth microdilution and well diffusion methods were used to determine the in vitro antidermatophytic activity. The in vivo study was carried out using 40 dermatophytosis-infected adults male Wistar rats. The animals were divided into 4 groups (5% and 10% G. corticata ointment, terbinafine, and Vaseline) and treated with ointment until complete recovery. The percentage of wound closure was calculated for each group.
Results: The results revealed that G. corticata methanol extract was effective to varying extents against the tested dermatophytes. The highest inhibitory activity of G. corticata was found against T. mentagrophytes with minimum inhibitory concentration and minimum fungicidal concentration values of 4 and 9 µg mL-1, respectively. The in vivo experiment revealed that 10% G. corticata ointment significantly accelerated skin lesions reduction and completely cured M. gypseum, T. mentagrophytes, and M. canis infections after 19, 25, and 38 days, respectively.
Conclusion: The methanol extract of G. corticata exhibited significant antifungal activity in vitro and in vivo, suggesting that it could be used as an alternative to antidermatophytic therapy in a dose-dependent manner.



  1. AL-Khikani FH. Dermatophytosis a worldwide contiguous fungal infection: Growing challenge and few solutions.Biomed Biotechnol Res J. 2020; 4:117.
  2. AL-Khikani FH, Ayit AS. Major challenges in dermatophytosis treatment: current options and future visions. Egypt J Dermatol Venerol. 2021; 41(1):1-9.
  3. Paryuni AD, Indarjulianto S, Widyarini S. Dermatophytosis in companion animals: A review. Vet World. 2020; 13(6):1174-81.
  4. Gautam SS, Babu N, Kumar S. Current perspective of dermatophytosis in animals. Fungal Diseases in Animals: Springer; 2021.
  5. Moriello KA. Dermatophytosis. Feline Dermatology: Springer; 2020.
  6. Gräser Y, Monod M, Bouchara JP, Dukik K, Nenoff P, Kargl A, et al. New insights in dermatophyte research. Med Mycol. 2018; 56(1):2-9.
  7. Mao L, Zhang L, Li H, Chen W, Wang H, Wu S, et al. Pathogenic fungus Microsporum canis activates the NLRP3 inflammasome. Infect Immun. 2014; 82(2):882-92.
  8. Aneke CI, Otranto D, Cafarchia C. Therapy and antifungal susceptibility profile of Microsporum canis. J Fungi. 2018; 4(3):107.
  9. Dolenc-Voljc M, Gasparic J. Human infections with Microsporum gypseum complex (Nannizzia gypsea) in Slovenia. Mycopathologia. 2017; 182(11):1069-75.
  10. Lopes G, Pinto E, Salgueiro L. Natural products: an alternative to conventional therapy for dermatophytosis? Mycopathologia. 2017; 182:143-67.
  11. Soares LA, Sardi JD, Gullo FP, Pitangui ND, Scorzoni L, Leite FS, et al. Anti dermatophytic therapy: prospects for the discovery of new drugs from natural products. Braz J Microbiol. 2013; 44:1035-41.
  12. Polat S, Trif M, Rusu A, Simat V, Cagalj M, Alak G, et al. Recent advances in industrial applications of seaweeds. Crit Rev Food Sci Nutr. 2021:1-30.
  13. Silva A, Silva SA, Carpena M, Garcia-Oliveira P, Gullón P, Barroso MF, et al. Macroalgae as a source of valuable antimicrobial compounds: Extraction and applications. Antibiotics. 2020; 9(10):642.
  14. Aziz E, Batool R, Khan MU, Rauf A, Akhtar W, Heydari M, et al. An overview on red algae bioactive compounds and their pharmaceutical applications. J Complement Integr Med. 2020; 17.
  15. Rosemary T, Arulkumar A, Paramasivam S, Mondragon-Portocarrero A, Miranda JM. Biochemical, micronutrient and physicochemical properties of the dried red seaweeds Gracilaria edulis and Gracilaria corticata. Molecules. 2019; 24(12):2225.
  16. Sharma B, Kumar P, Joshi SC. Topical treatment of dermatophytic lesion on mice (Mus musculus) model. Indian J Microbiol. 2011; 51:217-22.
  17. Saidani K, Bedjou F, Benabdesselam F, Touati N. Antifungal activity of methanolic extracts of four Algerian marine algae species. Afr J Biotechnol. 2012; 11:9496-500.
  18. Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 2020; 18(7):e3000410.
  19. Reference method for broth dilution antifungal susceptibility testing of filamentous Fungi. Approved Standard: CLSI document M38–A2, 2nd. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
  20. Falahati M, Fateh R, Nasiri A, Zaini F, Fattahi A, Farahyar S. Specific identification and antifungal susceptibility pattern of clinically important dermatophyte species isolated from patients with dermatophytosis in Tehran, Iran. Arch Clin Infect Dis. 2018; 13(3):e63104.
  21. Mohammadi R, Abbaszadeh S, Sharifzadeh A, Sepandi M, Taghdir M, Youseftabar Miri N, et al. In vitro activity of encapsulated lactic acid bacteria on aflatoxin production and growth of Aspergillus Spp. Food Sci Nutr. 2021; 9:1282-8.
  22. Kordjazi M, Shabanpour B, Zabihi E, Faramarzi MA, Gavlighi HA, Feghhi SMA, et al. Investigation of effects of fucoidan polysaccharides extracted from two species of Padina on the wound-healing process in the rat. Turk J Vet Anim Sci. 2017; 41:106-117.
  23. Savarirajan D, Ramesh VM, Muthaiyan A. In vitro antidermatophytic activity of bioactive compounds from selected medicinal plants. J Anal Sci Technol. 2021; 12(1):1-13.
  24. De Almeida CL, Falcão DS, Lima DM, Gedson R, Montenegro DA, Lira NS, et al. Bioactivities from marine algae of the genus Gracilaria. Int J Mol Sci. 2011; 12(7):4550-73.
  25. Kumar P, Selvi SS, Govindaraju M. Seaweed-mediated biosynthesis of silver nanoparticles using Gracilaria corticata for its antifungal activity against Candida Appl Nanosci. 2013; 3:495-500.
  26. Perez MJ, Falque E, Dominguez H. Antimicrobial action of compounds from marine seaweed. Mar Drugs. 2016; 14(3):52.
  27. Carvalho GLc, Silva R, Goncalves JM, Batista TM, Pereira L. Extracts of the seaweed Bifurcaria bifurcata display antifungal activity against human dermatophyte fungi. J Oceanol Limnol. 2019; 37:848-54.
  28. Subbiah M, Thennarasan S, Vajiravelu S. Effect of marine brown alga lobophora variegata (j.v.lamouroux) womersley exe.c.oliveir various solvents extracts on dermatophytes. Int J Pharm Sci Res. 2019; 10:672-7.
  29. Manam D, Kiran V. Anti-Fungal efficacy and secondary metabolite analysis of the methanolic extract from Colpomenia peregrina towards opportunistic fungal pathogens. Int J Innov Eng Manag Res. 2021; 10:89-100.
  30. Pandian P, Selvamuthukumar S, Manavalan R, Parthasarathy V. Screening of antibacterial and antifungal activities of red marine algae Acanthaphora spicifera (Rhodophyceae). J Biomed Sci Res. 2011; 3(3):444-8.
  31. Guedes EA, dos Santos Araújo MA, Souza AK, de Souza LI, de Barros LD, et al. Antifungal activities of different extracts of marine macroalgae against dermatophytes and Candida Mycopathologia. 2012; 174:223-32.
  32. Ghannadi A, Shabani L, Yegdaneh A. Cytotoxic, antioxidant and phytochemical analysis of Gracilaria species from Persian Gulf. Adv Biomed Res. 2016; 5:139.
  33. Lopes G, Pinto E, Andrade PB, Valentao P. Antifungal activity of phlorotannins against dermatophytes and yeasts: approaches to the mechanism of action and influence on Candida albicans virulence factor. PLoS One. 2013; 8(8):e72203.
  34. Oh KB, Lee JH, Chung SC, Shin J, Shin HJ, Kim HK, et al. Antimicrobial activities of the bromophenols from the red alga Odonthalia corymbifera and some synthetic derivatives. Bioorg Med Chem Lett. 2008; 18(1):104-8.
  35. Toreyhi H, Lotfali E, Fattahi A, Rezaee Y, Ghasemi R, Sabour ES. A Review on anti dermatophytosis potential of medicinal plants: in-vitro, in-vivo and important components. NBM. 2021; 9(2):71-100.
  36. Prasad CS, Shukla R, Kumar A, Dubey NK. In vitro and in vivo antifungal activity of essential oils of Cymbopogon martini and Chenopodium ambrosioides and their synergism against dermatophytes. Mycoses. 2010; 53(2):123-9.
  37. Njateng GSS, Gatsing D, Mouokeu RS, Lunga PK, Kuiate JR. In vitro and in vivo antidermatophytic activity of the dichloromethane-methanol (1: 1 v/v) extract from the stem bark of Polyscias fulva Hiern (Araliaceae). BMC Complement Altern Med. 2013; 13:1-10.
  38. Ayatollahi Mousavi SA, Kazemi A. In vitro and in vivo antidermatophytic activities of some Iranian medicinal plants. Med Mycol. 2015; 53:852-9.
  39. Wagini N, Abbas MS, Soliman AS, Hanafy YA, Badawy El-Saady M. In vitro and in vivo anti dermatophytes activity of Lawsonia inermis (henna) leaves against ringworm and its etiological agents. Am J Clin Exp Med. 2014; 2(3):51-8.
  40. Sun K, Song X, Jia R, Yin Z, Zou Y, Li L, et al. In vivo evaluation of Galla Chinensis solution in the topical treatment of dermatophytosis. Evid Based Complement Alternat Med. 2017; 2017:3843595.
  41. Lakshmi V, Srivastava S, Mishra SK, Khan ZK. Antifungal activity of marine algae of the Indian coast. Indian Drugs. 2010; 47:54-6.
  42. Mei YX, Dai XY, Yang W, Xu XW, Liang YX. Antifungal activity of chitooligosaccharides against the dermatophyte Trichophyton rubrum. Int J Biol Macromol. 2015; 77:330-5.
  43. Lopez-Moya F, Suarez-Fernandez M, Lopez-Llorca LV. Molecular mechanisms of chitosan interactions with fungi and plants. Int J Mol Sci. 2016; 20(2):332.
  44. Egusa M, Iwamoto R, Izawa H, Morimoto M, Saimoto H, Kaminaka H, et al. Characterization of chitosan nanofiber sheets for antifungal application. Int J Mol Sci. 2015; 16(11):26202-10.
  45. Radhika D, Mohaideen A. Fourier transform infrared analysis of Ulva lactuca and Gracilaria corticata and their effect on antibacterial activity. Asian J Pharm Clin Res. 2015; 8:209-12.
  46. El-Sheekh MM, El-Shafay SM, El-Ballat EM. In vivo evaluation of antimicrobial effect of methanolic extract of Chlorella vulgaris on impetigo and some dermatophytes. EJBO. 2016; 56(2):423-37.
  47. Narasimhan MK, Pavithra SK, Krishnan V, Chandrasekaran M. In vitro analysis of antioxidant, antimicrobial and antiproliferative activity of Enteromorpha antenna, Enteromorpha linza and Gracilaria corticata Jundishapur J Nat Pharm Prod. 2013; 8(4):151-9.
  48. Singh RS, Walia AK. Lectins from red algae and their biomedical potential. J Appl Phycol. 2018; 30(3):1833-58. do Nascimento-Neto LG, Carneiro RF, Da Silva SR, Da Silva BR, Vassiliepe Sousa Arruda F, Carneiro VA, et al. Characterization of isoforms of the lectin isolated from the red algae Bryothamnion seaforthii and its pro-healing effect. Mar Drugs. 2012; 10(9):1936-54.
  49.  do Nascimento-Neto LG, Carneiro RF, Da Silva SR, Da Silva BR,Vassiliepe Sousa Arruda F, Carneiro VA, et al. Characterization of isoforms of the lectin isolated from the red algae Bryothamnion seaforthii and its pro-healing effect. Mar Drugs. 2012;10(9):1936-54.